Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Parkinson's Disease”

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07813156
What this trial is testing

Idiopathic Parkinson's Disease: Interest of an Early Group-Based Cognitive Rehabilitation Program (LIFECOG-PD)

Who this might be right for
Parkinson Disease (PD)
University Hospital, Clermont-Ferrand 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07280299
What this trial is testing

Efficacy, Safety, Tolerability, and Biomarker Effects of GT-02287 in Early Parkinson's Disease

Who this might be right for
Parkinson Disease
Gain Therapeutics, Inc. 111
Large-scale testing (Phase 3)Study completedNCT00335166
What this trial is testing

SLV 308 and Pramipexole for Treatment of Patients With Early Parkinson Disease

Who this might be right for
Early Stage Parkinson Disease
Solvay Pharmaceuticals 330
Testing effectiveness (Phase 2)Study completedNCT00076492
What this trial is testing

NINDS Parkinson's Disease Neuroprotection Trial of CoQ10 and GPI 1485

Who this might be right for
Parkinson Disease
University of Rochester 195
Post-approval studies (Phase 4)Study completedNCT00321854
What this trial is testing

Study of (Mirapex) Pramipexole for the Early Treatment of Parkinsons Disease (PD)

Who this might be right for
Parkinson Disease
Boehringer Ingelheim 535
Testing effectiveness (Phase 2)Study completedNCT06329141
What this trial is testing

Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients

Who this might be right for
Parkinson Disease
Glaceum 99
Testing effectiveness (Phase 2)Study completedNCT00442780
What this trial is testing

Dose-Finding Safety Study of BIIB014 in Early-Stage Parkinson's Disease

Who this might be right for
Parkinson's Disease
Biogen 36
Not applicableUnknownNCT05477654
What this trial is testing

Motor-cognitive Dual-task in Healthy Older Adults and Early Parkinson's Disease Patients

Who this might be right for
Parkinson DiseaseMotor DisordersCognitive Impairment
Science and Research Centre Koper 60
Large-scale testing (Phase 3)Ended earlyNCT01155479
What this trial is testing

A Placebo- and Active-Controlled Study of Preladenant in Early Parkinson's Disease (PD) (P05664)

Who this might be right for
Parkinson Disease
Merck Sharp & Dohme LLC 1,022
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07804381
What this trial is testing

Disease-modifying Efficacy of Sitagliptin Therapy in Early-stage Parkinson's Disease

Who this might be right for
Parkinson Disease
Yonsei University 160
Early research (Phase 1)Study completedNCT02728947
What this trial is testing

Pharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's Disease

Who this might be right for
Parkinson's Disease
Luye Pharma Group Ltd. 28
Post-approval studies (Phase 4)UnknownNCT06236230
What this trial is testing

Basic and Clinical Studies of Levodopa/Carbidopa/Entacapone in the Treatment of Early Parkinson's Disease

Who this might be right for
Parkinson Disease
Second Affiliated Hospital of Soochow University 60
Not applicableLooking for participantsNCT06916507
What this trial is testing

Study to Assess Real Life Effectiveness of Foslevodopa/Foscarbidopa in Adult German Participants at Initial Stages of Advanced Parkinson's Disease (EARLY-FOS)

Who this might be right for
Parkinson's Disease
AbbVie 125
Large-scale testing (Phase 3)Study completedNCT00269516
What this trial is testing

SLV308 for Treatment of Patients With Early Parkinson's Disease

Who this might be right for
Early Stage Parkinson's Disease
Solvay Pharmaceuticals 468
Not applicableStudy completedNCT04340492
What this trial is testing

Education for Adapted Physical Activity in Parkinson's Disease

Who this might be right for
Parkinson Disease
University Hospital, Lille 89
Not applicableEnded earlyNCT00142311
What this trial is testing

Functional Characterization of Parkin + Patients

Who this might be right for
Parkinson's Disease
Institut National de la Santé Et de la Recherche Médicale, France 97
Testing effectiveness (Phase 2)Study completedNCT00134784
What this trial is testing

Long-Term Dopamine Transporter Imaging and Clinical Assessment of Parkinson's Disease Progression

Who this might be right for
Parkinson Disease
Institute for Neurodegenerative Disorders 142
Not applicableActive Not RecruitingNCT04261569
What this trial is testing

Clinical Trial for Near Infrared Endoventricular Illumination for Neuroprotection in Very Early Cases of Parkinson's Disease (Ev-NIRT)

Who this might be right for
Very Early Stage of Parkinson's Disease
University Hospital, Grenoble 14
Large-scale testing (Phase 3)Study completedNCT02168842
What this trial is testing

Efficacy of Isradipine in Early Parkinson Disease

Who this might be right for
Parkinson Disease
University of Rochester 336
Not applicableStudy completedNCT03779880
What this trial is testing

Examining Parkinson's Disease-Related Retirement: Results of Turkey

Who this might be right for
Parkinson Disease
Istanbul Kültür University 75
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation